| Previous Close | 17.46 |
| Open | 17.50 |
| Bid | 17.27 x 1200 |
| Ask | 17.30 x 1200 |
| Day's Range | 17.23 - 17.77 |
| 52 Week Range | 12.91 - 18.25 |
| Volume | 2,831,898 |
| Avg. Volume | 2,890,111 |
| Market Cap | 8.049B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Jan. 12, 2021 |
| Forward Dividend & Yield | 0.40 (2.34%) |
| Ex-Dividend Date | Jan. 25, 2021 |
| 1y Target Est | 20.94 |
- Zacks
Implied Volatility Surging for Albertsons (ACI) Stock Options
Investors need to pay close attention to Albertsons (ACI) stock based on the movements in the options market lately.
- Reuters
FOCUS-Some big U.S. pharmacies will not check ID before administering COVID-19 vaccines
Many U.S. pharmacies, including those inside Kroger Co supermarkets and the drugstore chain of CVS Health Corp, say they will not be checking IDs before administering COVID-19 vaccines, leaving the door open to those who do not meet states' guidelines to jump the line. While the United States has distributed more than 30 million vaccine doses, a little over 11 million had been administered as of Thursday, a lag that prompted U.S. health secretary Alex Azar to call on states to begin vaccinating the vulnerable older population and those with certain chronic health conditions to get more vaccines into arms. U.S. retailers face a choice of strictly enforcing state eligibility rules with on-site identity checks, or rely on an honor system that could allow people to ignore those guidelines but also get more people inoculated.
- Zacks
Albertsons (ACI) Q3 Earnings Beat Estimates, Sales Up Y/Y
Albertsons (ACI) third-quarter fiscal 2020 results reflect gains from identical sales growth. Moreover, management raises view for fiscal 2020.
